Cargando…

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and real-world effectiveness trials further suggest that antidepressant efficacy is limited in many patients. All currently approved antidepressant medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaso, Brittany A., Niciu, Mark J., Iadarola, Nicolas D., Lally, Níall, Richards, Erica M., Park, Minkyung, Ballard, Elizabeth D., Nugent, Allison C., Machado-Vieira, Rodrigo, Zarate, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327449/ https://www.ncbi.nlm.nih.gov/pubmed/26997505 http://dx.doi.org/10.2174/1570159X14666160321123221

Ejemplares similares

Neural Correlates of Suicidal Ideation and Its Reduction in Depression
por: Ballard, Elizabeth D., et al.
Publicado: (2015)

Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depressive Disorder
por: Kadriu, Bashkim, et al.
Publicado: (2017)

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
por: Xu, Annie J., et al.
Publicado: (2015)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
por: Richards, Erica M., et al.
Publicado: (2018)

Multilayer MEG functional connectivity as a potential marker for suicidal thoughts in major depressive disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine Has Distinct Electrophysiological and Behavioral Effects in Depressed and Healthy Subjects
por: Nugent, Allison C., et al.
Publicado: (2018)

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
por: Lally, N, et al.
Publicado: (2014)

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
por: Vecera, Courtney M., et al.
Publicado: (2023)

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder
por: Niciu, Mark J., et al.
Publicado: (2014)

SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration
por: Ameli, Rezvan, et al.
Publicado: (2014)

Research on the pathophysiology, treatment, and prevention of suicide: practical and ethical issues
por: Nugent, Allison C., et al.
Publicado: (2019)

cAMP Signaling in Brain is Decreased in Unmedicated Depressed Patients and Increased by Treatment with a Selective Serotonin Reuptake Inhibitor
por: Fujita, Masahiro, et al.
Publicado: (2016)

Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
por: Sarawagi, Ajay, et al.
Publicado: (2021)

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
por: Park, Lawrence, et al.
Publicado: (2018)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita, Masatoshi, et al.
Publicado: (2018)

Network Changes in Insula and Amygdala Connectivity Accompany Implicit Suicidal Associations
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
por: de Sousa, Rafael T., et al.
Publicado: (2015)

Bimodal Effect of Lithium Plasma Levels on Hippocampal Glutamate Concentrations in Bipolar II Depression: A Pilot Study
por: Zanetti, Marcus V., et al.
Publicado: (2015)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression
por: Bernard, René, et al.
Publicado: (2010)

A Predictive Coding Framework for Understanding Major Depression
por: Gilbert, Jessica R., et al.
Publicado: (2022)

Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression
por: Haroon, E, et al.
Publicado: (2016)

Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Kumar, Pooja, et al.
Publicado: (2021)

Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
por: Borentain, Stephane, et al.
Publicado: (2022)

Preliminary evidence that early reduction in p11 levels in Natural Killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram
por: Svenningsson, P, et al.
Publicado: (2014)

Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling
por: Gilbert, Jessica R, et al.
Publicado: (2018)

Prognosis and improved outcomes in major depression: a review
por: Kraus, Christoph, et al.
Publicado: (2019)

Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders
por: Baldassarri, Stephen R., et al.
Publicado: (2023)

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
por: Reed, Jessica L., et al.
Publicado: (2018)

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
por: Mkrtchian, Anahit, et al.
Publicado: (2020)

Atopic Dermatitis and Major Depressive Disorder: is there causality?
por: Reis, C. S., et al.
Publicado: (2023)

Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder
por: Kantrowitz, Joshua T., et al.
Publicado: (2021)

Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Khan, Tauseef A., et al.
Publicado: (2021)

The Dynamic Relationship Between Alpha and Beta Power and Next-Day Suicidal Ideation in Individuals With Treatment-Resistant Depression
por: Ballard, Elizabeth D., et al.
Publicado: (2021)

Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation
por: Grillon, Christian, et al.
Publicado: (2013)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology
por: Alario, Alexandra A., et al.
Publicado: (2021)

(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy
por: Alario, Alexandra A., et al.
Publicado: (2022)

The Role of Glutamate Underlying Treatment-resistant Depression
por: Kim, Jeongseop, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5dtis8uouie9st0u5k8jh13bj